Search
Morgan Stanley Pathway Small-Mid Cap Equity ETF
MSSMAdd to Watchlist
57.099USD
+0.289+0.51%
Close 11-06 16:00（ET）
300.00Volume
17.11KTurnover
Today
+0.51%
5 Days
-1.44%
1 Month
-0.05%
6 Months
-1.18%
Year to Date
+12.84%
1 Year
+15.77%
Key Figures
56.720Open
56.810Prev. Close
59.020High
56.646Low
300.00Volume
17.11KTurnover
0.07Volume Ratio
62.08052wk High
47.03652wk Low
12.99KAvg Volume
0.57%Div Yield
0.324Est. Annual Div.
Extended MarketInvestment Segment
NoInverse ETF
NoLeveraged ETF
--Leverage Factor
57.057NAV
USDNAV Currency
2.52P/B
18.40Price to earnings ratio
Morgan Stanley Pathway Small-Mid Cap Equity ETF Profile
Ticker SymbolMSSM
Asset ClassEquity
Fund ManagerMorgan Stanley
DomicileUS
Expense Ratio0.62%
Founded at2024-12-09
Tracking Index--
MSSM was created on 2024-12-09 by Morgan Stanley. The fund's investment portfolio concentrates primarily on extended market equity. The ETF currently has 689.2m in AUM and 1819 holdings. MSSM seeks capital appreciation through an actively managed portfolio of US mid- and small-cap equity securities. The fund utilizes a multi-manager strategy in constructing the portfolio.
Top 10 Holdings
No.Name
Price
Change
Chg %
Shares Held
Weight
Market Value
Watchlist
Dynatrace Inc Ordinary Shares
DT
43.440
-0.260
-0.59%
102.76K
0.96%
$6.58M
Ascendis Pharma AS
ASND
256.820
+3.370
+1.33%
21.46K
0.76%
$5.22M
KBR Inc
KBR
37.170
-0.870
-2.29%
119.84K
0.69%
$4.70M
4
Viasat Inc
VSAT
63.950
+4.570
+7.70%
67.12K
0.60%
$4.13M
5
Haemonetics Corp
HAE
119.930
-4.180
-3.37%
34.40K
0.60%
$4.08M
6
TechnipFMC PLC
FTI
63.520
+1.930
+3.13%
52.38K
0.53%
$3.66M
7
Texas Capital Bancshares Inc
TCBI
103.090
-2.940
-2.77%
35.01K
0.52%
$3.57M
8
Moderna Inc
MRNA
254.190
+12.730
+5.27%
17.68K
0.52%
$3.54M
9
Life Time Group Holdings Inc
LTH
47.120
-0.630
-1.32%
84.25K
0.52%
$3.53M
10
Veeco Instruments Inc
VECO
37.190
+3.940
+11.85%
82.72K
0.51%
$3.48M
Morgan Stanley Pathway Small-Mid Cap Equity ETF Technical Analysis
Technical Indicators
Strong sell
Summary
Sell
Moving Average
Strong sell
Morgan Stanley Pathway Small-Mid Cap Equity ETF News
More news coming soon, stay tuned...
Popular Instruments
51290.600
-208.500 (-0.41%)
26964.500
+329.300 (+1.24%)
7380.000
+23.100 (+0.31%)
12797.000
-1.000 (-0.01%)
58142.000
+876.000 (+1.53%)
6140.600
-37.200 (-0.60%)
89.857
-0.176 (-0.20%)
342.370
-1.800 (-0.52%)
186.640
+5.040 (+2.78%)
4065.670
-33.020 (-0.81%)
FAQs
What is the current price of Morgan Stanley Pathway Small-Mid Cap Equity ETF (MSSM)?
The current price of Morgan Stanley Pathway Small-Mid Cap Equity ETF (MSSM) is 57.10. Market data may be delayed; please refer to the timestamp displayed on the page.
What is the 52-week high of Morgan Stanley Pathway Small-Mid Cap Equity ETF?
The 52-week high of Morgan Stanley Pathway Small-Mid Cap Equity ETF is 62.08. Please refer to the page timestamp for the latest data.
What is the 52-week low of Morgan Stanley Pathway Small-Mid Cap Equity ETF?
The 52-week low of Morgan Stanley Pathway Small-Mid Cap Equity ETF is 47.04. Please refer to the page timestamp for the latest data.
What is the NAV of Morgan Stanley Pathway Small-Mid Cap Equity ETF?
The NAV of Morgan Stanley Pathway Small-Mid Cap Equity ETF is 57.06 today. NAV represents the fund’s total assets minus its liabilities and helps indicate its underlying per-share value.
How is Morgan Stanley Pathway Small-Mid Cap Equity ETF (MSSM) performing?
The trading turnover of Morgan Stanley Pathway Small-Mid Cap Equity ETF (MSSM) is 17.11K. Its price changed by -0.86% over the past month, while its one-year return is 15.77%. View the Morgan Stanley Pathway Small-Mid Cap Equity ETF price chart for more details.
Is Morgan Stanley Pathway Small-Mid Cap Equity ETF (MSSM) a safe investment?
No investment is completely risk-free. The risk level of Morgan Stanley Pathway Small-Mid Cap Equity ETF (MSSM) depends on its underlying assets, strategy, liquidity, fees, and market conditions. Diversification may reduce potential losses but cannot eliminate them, and past performance does not guarantee future results. Before investing, consider whether the fund aligns with your goals and risk tolerance. This is not investment advice.